Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the initiation of a Phase 2 ...
Australians who have had their mental health conditions misdiagnosed say that the standard procedure for diagnosis has limitations and that building rapport with trusted psychologists leads to better ...